Structure and inhibition of orotidine 5'-monophosphate decarboxylase from Plasmodium falciparum
Structure and inhibition of orotidine 5'-monophosphate decarboxylase from Plasmodium falciparum
复制标题
DOI:
10.1021/bi702390k
复制
发表时间:
2008-03-25
期刊:
影响因子:
2.9
通讯作者:
Christopherson, Richard I.
中科院分区:
文献类型:
--
作者:
Langley, David B.;Shojaei, Maryam;Christopherson, Richard I.
Orotidine 5'-monophosphate (OMP) decarboxylase from Plasmodium falciparum (PfODCase, EC 4.1.1.23) has been overexpressed, purified, subjected to kinetic and biochemical analysis, and crystallized. The native enzyme is a homodimer with a subunit molecular mass of 38 kDa. The saturation curve for OMP as a substrate conformed to Michaelis-Menten kinetics with Km = 350 +/- 60 nM and V-max = 2.70 +/- 0.10 mu mol/min/mg protein. Inhibition patterns for nucleoside 5'-monophosphate analogues were linear competitive with respect to OMP with a decreasing potency of inhibition of PfODCase in the order: pyrazofurin 5'-monophosphate (K-i = 3.6 +/- 0.7 nM) > xanthosine 5'-monophosphate (XMP, K-i = 4.4 +/- 0.7 nM) > 6-azauridine 5'-monophosphate (AzaUMP, K-i = 12 +/- 3 nM) > allopurinol-3-riboside 5'-monophosphate (Ki = 240 20 nM). XMP is an similar to 150-fold more potent inhibitor of PfODCase compared with the human enzyme. The structure of PfODCase was solved in the absence of ligand and displays a classic TIM-barrel fold characteristic of the enzyme. Both the phosphate-binding loop and the beta alpha 5-loop have conformational flexibility, which may be associated with substrate capture and product release along the reaction pathway.